title: Agomelatine improves sleep in a patient with fatal familial insomnia.
abstract: A young patient with FFI was started on agomelatine 25 mg to medicate nocturnal insomnia. Under this treatment sleep efficiency was improved, slow wave sleep was high and awakenings during sleep period time were far less than before. Clinically the patient was less restless during nighttime.
authors: T
authors: T
authors: Froböse
authors: H
authors: H
authors: Slawik
authors: R
authors: R
authors: Schreiner
authors: Z
authors: Z
authors: Veselý
authors: M
authors: M
authors: Wiegand
authors: J
authors: J
authors: Bäuml
authors: H
authors: H
authors: Förstl
mesh_terms: D000081:Acetamides / Q000627:therapeutic use*; D000328:Adult; D004827:Epilepsy / Q000209:etiology; D017809:Fatal Outcome; D005260:Female; D006801:Humans; D006993:Hypnotics and Sedatives / Q000627:therapeutic use*; D034062:Insomnia, Fatal Familial / Q000188:drug therapy* / Q000503:physiopathology; D012720:Severity of Illness Index; D012894:Sleep Stages / Q000187:drug effects; D016896:Treatment Outcome; D009281:Naphthalenes
chemical_list: D000081:Acetamides; D006993:Hypnotics and Sedatives; C084711:agomelatine; D009281:Naphthalenes